disease interaction(s) of coronary artery disease with HFpEF

Management

• nitrates
  • reduction in angina
  • increase in exercise tolerance
  • do not affect prognosis
• ranolazine if other options exhausted
  • symptomatic relief only
  • ranolazine may be best used in patients with persistent symptoms who cannot tolerate up-titration or optimization of alternative regimens
    • not what OpenEvidence recommends

More general terms

• disease interaction